Core Laboratories vs National Energy Services Reunited
CLB and NESR side by side, both in oil and gas field services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLB and NESR compare
National Energy Services Reunited grew revenue faster over the last twelve months (44.0% versus −0.15% for Core Laboratories).
National Energy Services Reunited keeps more of each dollar of sales as profit, with a net margin of 6.0% compared with 3.0% at Core Laboratories.
Core Laboratories pays a dividend yielding 0.33%; National Energy Services Reunited does not pay one.
National Energy Services Reunited scores higher on the StockData Score (13 against 11 for Core Laboratories), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLB | NESR |
|---|---|---|
| Size and price | ||
| Market cap | $414M | – |
| Share price | $9.04 | $21.98 |
| Change, 1 year | −41.5% | 67.0% |
| Change, 5 years | −62.9% | 116% |
| Beta (5Y) | 1.14 | 0.88 |
| Employees | 3,300 | 1,818 |
| StockData Score | ||
| Total score | 11 | 13 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 5 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 26.6× | – |
| P/S | 0.8× | – |
| P/B | 1.5× | – |
| EV/EBITDA | 9.5× | – |
| P/FCF | 40.0× | – |
| PEG | 1.84 | – |
| FCF yield | 2.5% | – |
| Fair value | $8.17 | – |
| Margin of safety | −10.7% | – |
| Growth | ||
| Revenue growth (TTM) | −0.15% | 44.0% (better) |
| Revenue growth, 5Y average | – | 9.7% |
| Net income growth (TTM) | −51.6% | 56.7% (better) |
| EPS growth (TTM) | −50.0% | 46.6% (better) |
| EPS growth, 5Y average | – | 23.6% |
| Profitability | ||
| Gross margin | 19.1% (better) | 13.7% |
| Operating margin | 7.5% | 10.1% (better) |
| Net margin | 3.0% | 6.0% (better) |
| FCF margin | 2.0% | 7.9% (better) |
| Return on equity | 5.7% | 10.8% (better) |
| Return on invested capital | 6.0% | 11.1% (better) |
| Financial health | ||
| Debt / equity | 0.40 | 0.25 (better) |
| Net debt / EBITDA | 1.69 | 0.49 (better) |
| Interest coverage | 3.5× | 6.6× (better) |
| Current ratio | 2.19 (better) | 1.01 |
| Altman Z-score | 2.57 | – |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.33% | – |
| Payout ratio | 11.9% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 2.5% | – |
| Shareholder yield | 2.8% | – |
| Ownership | ||
| Held by institutions | 115% | 69.6% |
| Held by insiders | 1.5% | 32.6% |
| Insider net buying, 12 months | $53.9K (better) | −$142M |
| Short interest, % of float | 11.0% | 7.2% |
Go deeper
- CLB stock overview
- CLB income statement
- CLB valuation and score
- NESR stock overview
- NESR income statement
- NESR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.